Search Results - "Arroyo Martin, Ignacio"

Digital Polymerase Chain Reaction (dPCR) Versus Flow Cytometry (FC), a Validation Study for CAR-T Cell Product Optimal Detection by Ventura, Laura, Serrano, Alicia, Ferrer Lores, Blanca, Amat Martinez, Paula, Remigia Pellicer, Maria Jose, Pastor Galan, Irene, Coll Ferri, Paula, Ara Navarro, Julia, Espinosa Molina, Paula, Montolio Baselga, Elena, Mellado Soriano, Inmaculada, Teruel, Ana Isabel, Saus Carreres, Ana, Arroyo Martin, Ignacio, Ortiz Algarra, Alfonso, Benzaquen, Ana, Perez, Ariadna, Pinana Sanchez, Jose Luis, Hernani, Rafael, Hernandez Boluda, Juan Carlos, Solano, Carlos, Terol, María José

“…Adoptive immunotherapy with Chimeric Antigen Receptor - T cells (CAR-T), has revolutionized hematological treatment mainly in relapsed/refractory (r/r) B-cell…”
Get full text

Digital PCR Assay for Evaluation of CD19-CAR-T Cells In Vivo Expansion in Aggressive B-Cell Lymphoma: Impact on Clinical Outcome by Ventura, Laura, Serrano, Alicia, Ferrer Lores, Blanca, Hernani, Rafael, Vasile Tudorache, Alexandru Robert, Teruel, Ana Isabel, Saus Carreres, Ana, Ortiz Algarra, Alfonso, Arroyo Martin, Ignacio, Hernandez Boluda, Juan Carlos, Pinana Sanchez, Jose Luis, Perez, Ariadna, Benzaquen, Ana, Solano, Carlos, Terol Castera, Maria Jose

“…Background: Chimeric antigen receptor (CAR)-T cells therapy has revolutionized hematological treatment mainly in non-Hodgkin lymphoma (NHL) demonstrating…”
Get full text

CART-AI-Radiomics: Survival and Neurotoxicity Prediction in B-Cell Lymphoma Patients Treated with CAR-T Cells through an Imaging Features-Based Model by Ferrer Lores, Blanca, Serrano, Alicia, Hernani, Rafael, Sopena-Novales, Pablo, Ventura Lopez, Laura, Teruel, Ana Isabel, Ortiz Algarra, Alfonso, Saus Carreres, Ana, Arroyo Martin, Ignacio, Vasile Tudorache, Alexandru Robert, Pinana Sanchez, Jose Luis, Hernandez Boluda, Juan Carlos, Perez, Ariadna, Benzaquen, Ana, Balaguer Rosello, Aitana, Guerreiro, Manuel, Sanz, Jaime, Fuster-Matanzo, Almudena, Picó, Alfonso, Estepa-Fernández, Alejandra, Fernández, Juan Pedro, Bellvís-Bataller, Fuensanta, Weiss, Glen J, Solano, Carlos, Terol, Maria José

“…Background: Despite clinical outcome improvements observed in relapsed/refractory (R/R) B-cell lymphoma patients (pts) treated with antigen receptor modified…”
Get full text